WELDING GmbH & Co. KG and Vantage Hemp Forge Strategic Partnership to Supply Pharmaceutical Industry with High-Quality Cannabinoid Raw Materials

Hamburg, October 17th 2025 – WELDING GmbH & Co. KG, an internationally operating life sciences service provider based in Hamburg, and Vantage Hemp Co., a leading manufacturer of pharmaceutical-grade cannabinoid raw materials from Colorado, USA, announce their strategic partnership. This collaboration aims to supply the European pharmaceutical industry with high-quality, GMP-certified cannabidiol (CBD) raw materials.

Vantage Hemp Co. specializes in the production of botanically derived, pharmaceutical-grade CBD products. The company operates cGMP-certified production facilities that comply with international standards such as FDA 21 CFR 210/211, ICH Q7, PIC/S, and WHO GMP. Vantage Hemp’s products meet the specifications of the European Pharmacopoeia for CBD isolate and are approved for the international market.

The production methodologies employed by Vantage Hemp ensure that their products are not only of the highest quality but also meet stringent regulatory requirements. This compliance with standards highlights Vantage Hemp’s commitment to excellence. The advanced extraction and purification processes used by Vantage Hemp result in cannabinoid raw materials with unmatched purity and consistency, making them ideal for pharmaceutical applications. These products are vital components in the formulation of innovative therapies designed to enhance patient outcomes and contribute to the advancement of medicine.

WELDING GmbH & Co. KG, based in Hamburg (Germany), is a family-owned company with over 70 years of international experience. The company specializes in the sourcing and distribution of pharmaceutical active ingredients, food additives, and feed additives, as well as the development, registration, licensing, and supply of generic medicines. In this context, WELDING also offers a comprehensive range of services in quality assurance and regulatory affairs. This strategic partnership allows us to meet the growing demand for sustainably sourced, high-quality cannabinoid raw materials in European Union, the European Economic Area, Switzerland, India and North Macedonia. By combining our expertise in quality management and regulatory compliance with Vantage Hemp’s superior production capabilities, we ensure that our pharmaceutical industry clients receive raw materials that consistently meet and exceed their expectations. The commitment to quality and safety that both WELDING and Vantage Hemp uphold guarantees that every product delivered is not only reliable but also compliant with the highest regulatory standards.

Statement from Boy Ehlers (Managing Director of WELDING GmbH & Co. KG):

“All the great blessings of digitalization notwithstanding, our business remains a people’s business, and our new strategic partnership with Vantage beautifully proves that point.  It grew out of long-standing relationships between people who have known and trusted each other in different roles across the industry. That mutual trust and respect laid the foundation for our first discussions, which have now culminated in a signed distribution agreement. This cooperation further strengthens Welding’s position as a reliable supplier of innovative active ingredients for the pharmaceutical industry and enables us to offer our customers an expanded portfolio of cannabinoid raw materials. By combining Vantage Hemp’s profound expertise in manufacturing pharmaceutical-grade cannabinoid raw materials with Welding’s 70 years of experience in life science ingredient distribution, we aim to be an integral part of the CBD success story, together with our customers in Europe and beyond.”

Statement from Harvinder Johal (Chief Revenue Officer, Vantage Hemp):

“Through our partnership with Welding GMBH, Vantage Hemp is primed to unlock true global scale. This agreement aligns our sales and marketing efforts, leverages deep technical resources across both teams, and creates a robust supply chain for pharmaceutical grade CBD across the EU. Our combined team will drive efficient route-to-market execution and elevate accessibility worldwide.”

Statement from Deepank Utkhede (COO & Chief Process Biochemist, Vantage Hemp):

“Our regulatory roadmap demonstrates Vantage Hemp’s commitment to pharmaceutical standards. We already have two DMFs with the FDA, PIC/S certification from the TGA, and are presently awaiting our CBPF inspection from ANVISA. Having Welding onboard to support our upcoming ASMF and CEP submission strengthens our ability to meet EMA expectations and expand into clinical and commercial applications in the EU.”

About WELDING GmbH & Co. KG:

WELDING GmbH & Co. KG, based in Hamburg, is a family-owned company with over 70 years of international experience. The company specializes in the procurement and distribution of pharmaceutical active ingredients, food additives, and feed additives, as well as the development, approval, licensing, and delivery of generic pharmaceuticals. In this regard, WELDING also offers a comprehensive range of services in the field of quality assurance and regulatory affairs.

About Vantage Hemp Co.:

Vantage Hemp Co., based in Greeley, Colorado, is a leading manufacturer of pharmaceutical-grade cannabinoid raw materials. The company produces CBD and CBG products in cGMP-certified facilities, adhering to international quality standards and approved for the global market. Their commitment to producing top-tier, botanically derived cannabinoid products that meet global regulatory requirements positions them as a trusted supplier in the life sciences industry.
For more information, please visit:

Press Contact:
WELDING GmbH & Co. KG – Esplanade 39 – 20354 Hamburg – Phone: +49 40 359080 – Email: pharma-contact@welding.eu
Vantage Hemp Co. Greeley – Colorado, USA Email: info@vantagehemp.com